Vaccinex Profit Margin 2017-2021 | VCNX
Current and historical gross margin, operating margin and net profit margin for Vaccinex (VCNX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Vaccinex net profit margin as of September 30, 2021 is 0%.
|Vaccinex Annual Profit Margins
|Vaccinex Quarterly Profit Margins
||Medical - Biomedical and Genetics
Vaccinex, Inc. is a clinical-stage immunotherapy company. It engages in the discovery and development of biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The company's product pipeline consists of VX15, VX5 and VX25 which are in clinical stage. Vaccinex, Inc. is based in Rochester, New York.